The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

American Journal of Public Health
J TuttleS Hadler

Abstract

This study examined whether there is a risk that tetanus-toxoid-containing vaccines could cause Guillain-Barré syndrome and, if so, how large the risk is. This study was based on previous active surveillance epidemiological studies of Guillain-Barré syndrome and vaccination history. A background rate of 0.3 cases of Guillain-Barré syndrome per million person-weeks has been estimated. By chance, 2.2 people with the syndrome would have received tetanus-toxoid-containing vaccine within the 6 weeks before onset, yet only 1 person had done so. Data on children show similar results. If an association exists, it must be extremely rare and not of public health significance.

References

Feb 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P M StrebelA R Hinman
May 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·J B WinerR P Watkins
Feb 2, 1987·The Medical Journal of Australia·G J Hankey

❮ Previous
Next ❯

Citations

Oct 5, 2010·Clinical Reviews in Allergy & Immunology·Eitan IsraeliYehuda Shoenfeld
Mar 1, 2000·Journal of Neuroimmunology·R A HughesK J Smith
Aug 20, 2002·Vaccine·C J Clements, E Griffiths
Apr 26, 2002·Toxicology·J DescotesC Ruat
Mar 5, 2002·Journal of Midwifery & Women's Health·Barbara K Hackley
Dec 17, 1998·The New England Journal of Medicine·A H Ropper, M Victor
Jul 28, 2006·Pediatric Emergency Care·Franz E BablLance Brown
Sep 20, 2000·Ugeskrift for laeger·C Krarup, S Vorstrup
Aug 18, 2000·Paediatric Drugs·R T ChenF DeStefano
May 4, 2010·Annals of Indian Academy of Neurology·Abhishek SrivastavaT Murali
May 9, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Ralph Edwards
Feb 7, 1998·American Journal of Public Health·R F Breiman, J A Zanca
Sep 1, 2001·Expert Review of Neurotherapeutics·J M Spies, K A Sheikh
Aug 1, 2013·Expert Review of Clinical Immunology·Benjamin R Wakerley, Nobuhiro Yuki
Sep 5, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Ralph Edwards
Apr 25, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Penina HaberFrank DeStefano
Mar 24, 2009·Neuromuscular Disorders : NMD·Kenneth A Myers, Steven K Baker
Dec 7, 2010·Vaccine·James D NordinEric Weintraub
Oct 14, 2008·Lancet Neurology·Pieter A van DoornBart C Jacobs
Aug 7, 2018·Neurologia Medico-chirurgica·Satoru YonekuraNobuyuki Kobayashi
Dec 16, 1998·Current Opinion in Neurology·H P HartungJ D Pollard
Jul 19, 2005·Emerging Infectious Diseases·James J SejvarLyle R Petersen
Mar 2, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Ralph Edwards
Mar 25, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rebecca Ellen ChandlerMarie Lindquist
Apr 28, 2018·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Jennifer L LiangThomas A Clark
Jun 13, 2021·Neurology and Therapy·Haruki KoikeMasahisa Katsuno
Jul 8, 2021·Clinical & Experimental Neuroimmunology·Haruki Koike, Masahisa Katsuno
Jul 13, 2021·Annals of Medicine and Surgery·Almurtada RazokMuhammad Zahid

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.